These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28336532)

  • 1. MOAG-4 promotes the aggregation of α-synuclein by competing with self-protective electrostatic interactions.
    Yoshimura Y; Holmberg MA; Kukic P; Andersen CB; Mata-Cabana A; Falsone SF; Vendruscolo M; Nollen EAA; Mulder FAA
    J Biol Chem; 2017 May; 292(20):8269-8278. PubMed ID: 28336532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation.
    Pras A; Houben B; Aprile FA; Seinstra R; Gallardo R; Janssen L; Hogewerf W; Gallrein C; De Vleeschouwer M; Mata-Cabana A; Koopman M; Stroo E; de Vries M; Louise Edwards S; Kirstein J; Vendruscolo M; Falsone SF; Rousseau F; Schymkowitz J; Nollen EAA
    EMBO J; 2021 Nov; 40(21):e107568. PubMed ID: 34617299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity.
    van Ham TJ; Holmberg MA; van der Goot AT; Teuling E; Garcia-Arencibia M; Kim HE; Du D; Thijssen KL; Wiersma M; Burggraaff R; van Bergeijk P; van Rheenen J; Jerre van Veluw G; Hofstra RM; Rubinsztein DC; Nollen EA
    Cell; 2010 Aug; 142(4):601-12. PubMed ID: 20723760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.
    Xie YY; Zhou CJ; Zhou ZR; Hong J; Che MX; Fu QS; Song AX; Lin DH; Hu HY
    FASEB J; 2010 Jan; 24(1):196-205. PubMed ID: 19762560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.
    Hideshima M; Kimura Y; Aguirre C; Kakuda K; Takeuchi T; Choong CJ; Doi J; Nabekura K; Yamaguchi K; Nakajima K; Baba K; Nagano S; Goto Y; Nagai Y; Mochizuki H; Ikenaka K
    Sci Rep; 2022 Jan; 12(1):351. PubMed ID: 35013421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disordered protein SERF promotes α-Synuclein aggregation through liquid-liquid phase separation.
    Liu HN; Wang T; Hu JJ; Chen L; Shi X; Li YM; Luo SZ
    J Biol Chem; 2024 Mar; 300(3):105667. PubMed ID: 38272228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.
    Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into α-synuclein monomer-fibril interactions.
    Kumari P; Ghosh D; Vanas A; Fleischmann Y; Wiegand T; Jeschke G; Riek R; Eichmann C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein.
    Tyson T; Senchuk M; Cooper JF; George S; Van Raamsdonk JM; Brundin P
    Sci Rep; 2017 Aug; 7(1):7506. PubMed ID: 28790319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tale of dual functions of SERF family proteins in regulating amyloid formation.
    Qi S; Peng Y; Wang G; Zhang X; Liu M; He L
    Chembiochem; 2024 Mar; 25(5):e202300727. PubMed ID: 38100267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
    Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
    Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans.
    Maulik M; Mitra S; Hunter S; Hunstiger M; Oliver SR; Bult-Ito A; Taylor BE
    Sci Rep; 2018 Jul; 8(1):10216. PubMed ID: 29976995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERF protein is a direct modifier of amyloid fiber assembly.
    Falsone SF; Meyer NH; Schrank E; Leitinger G; Pham CL; Fodero-Tavoletti MT; Holmberg M; Dulle M; Scicluna B; Gesslbauer B; Rückert HM; Wagner GE; Merle DA; Nollen EA; Kungl AJ; Hill AF; Cappai R; Zangger K
    Cell Rep; 2012 Aug; 2(2):358-71. PubMed ID: 22854022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Fuzziness of the RNA-Organizing Protein SERF Determines a Toxic Gain-of-interaction.
    Meyer NH; Dellago H; Tam-Amersdorfer C; Merle DA; Parlato R; Gesslbauer B; Almer J; Gschwandtner M; Leon A; Franzmann TM; Grillari J; Kungl AJ; Zangger K; Falsone SF
    J Mol Biol; 2020 Feb; 432(4):930-951. PubMed ID: 31794729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation.
    Sin O; de Jong T; Mata-Cabana A; Kudron M; Zaini MA; Aprile FA; Seinstra RI; Stroo E; Prins RW; Martineau CN; Wang HH; Hogewerf W; Steinhof A; Wanker EE; Vendruscolo M; Calkhoven CF; Reinke V; Guryev V; Nollen EA
    Mol Cell; 2017 Mar; 65(6):1096-1108.e6. PubMed ID: 28306505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.